# CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma

> **NCT03063450** · PHASE3 · COMPLETED · sponsor: **University of Southampton** · enrollment: 332 (actual)

## Conditions studied

- Mesothelioma

## Interventions

- **DRUG:** Nivolumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03063450
- **Lead sponsor:** University of Southampton
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-28
- **Primary completion:** 2023-02-07
- **Final completion:** 2023-02-07
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063450, "CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03063450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*